李 偉華

Medicine & Life Sciences

1. Neoplasms 100%
2. Neoplastic Stem Cells 77%
3. Hepatocellular Carcinoma 61%
4. Neoplasm Metastasis 57%
5. Glioma 44%
6. Down-Regulation 42%
7. Cell Line 38%
8. 4-acetylantroquinonol B 37%
9. Apoptosis 37%
10. pterostilbene 37%
11. Adenocarcinoma 36%
12. Nasopharyngeal Carcinoma 36%
13. ovatodiolide 35%
14. Glioblastoma 32%
15. Immunoglobulin A 32%
16. Cisplatin 31%
17. Carcinoma 31%
18. Antigen-Antibody Complex 29%
19. Proteinuria 29%
20. Breast Neoplasms 28%
21. Phenotype 27%
22. Therapeutics 26%
23. Tissue Array Analysis 26%
24. Brain 26%
25. MicroRNAs 26%
26. Meningioma 25%
27. Human Herpesvirus 4 25%
28. Hemangiopericytoma 23%
29. Nude Mice 22%
30. Myeloid-Derived Suppressor Cells 22%
31. Colorectal Neoplasms 21%
32. Stem Cells 21%
33. Growth 21%
34. Carcinogenesis 21%
35. Drug Therapy 20%
36. Catenins 20%
37. Antrodia 20%
38. signal peptide peptidase 19%
39. Epithelial-Mesenchymal Transition 19%
40. Stomach 19%
41. In Vitro Techniques 18%
42. Squamous Cell Carcinoma 18%
43. matriptase 18%
44. osthol 18%
45. Metalloproteases 17%
46. Kidney 17%
47. Adenocarcinoma of Lung 17%
48. Recurrence 17%
49. Blueberry Plants 16%